drugset / Trial / NCT06084130

Zolpidem on CPAP Acclimatization in OSA

NCT06084130

Phase 4 Unknown 30 enrolled Siriraj Hospital
RandomizedCrossoverQuadruple-blindTreatment

Summary

Obstructive sleep apnea (OSA) is a sleep disorder characterized by a cessation or significant decrease in airflow during sleep. CPAP is the preferred therapy and has high effectiveness at all levels of OSA severity. It acts as a pneumatic splint to maintain upper airway patency during sleep, preventing the soft tissues from collapsing. However, the patient's compliance continues to be an issue. One of the main contributors to CPAP therapy failure is difficulty falling asleep. To aid in the machine's adaptation, hypnotic medicine was administered.

Timeline

Start
2023-10-15
Primary completion
2024-10-15
Completion
2024-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Zolpidem Small molecule 10 mg Oral